More News! 16 Apr 2018
Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases
The British-Belgian biotech Apitope has obtained positive Phase I results for its first-in-class treatment for Graves' disease, one of the most common autoimmune diseases. Apitope has obtained positive clinical results…